The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Target Depletion of Distinct Tumor Necrosis Factor Receptor Subtypes Reveals Hippocampal Neuron Death and Survival through Different Signal Transduction Pathways
Open accessAbstract
Tumor necrosis factor receptor-I (TNFRI) and TNFRII are two TNFR subtypes in the immune system, but their roles in the brain remain unclear. Here we present a novel interaction between TNFR subtypes and TNF-alpha in the brain. Our studies on target-depleted TNFR in mice show that TNF-alpha has little effect on hippocampal neurons in which TNFRI, containing an "intracellular death domain," is absent (TNFRI -/-), whereas neurons from TNFRII knock-out mice are vulnerable to TNF-alpha even at low doses. Moreover, little nuclear factor-kappaB (NF-kappaB) translocation is induced by TNF-alpha in neurons of TNFRI -/-, whereas NF-kappaB subunit p65 is still translocated from the cytoplasm into the nucleus in neurons from wild-type and TNFRII -/- mice. Furthermore, p38 mitogen-activated protein (MAP) kinase activity is upregulated in neurons from both wild-type and TNFRI -/-, but no alteration of p38 MAP kinase was found in neurons from TNFRII. Results from overexpression of TNF receptors further support the above findings. NT2 neuronal-like cells transiently transfected with TNFRI are very sensitive to TNF-alpha, whereas TNF-alpha is not toxic and even seems to be trophic to the cells with TNFRII overexpression. Last, our radioligand-binding experiments demonstrate that TNF-alpha binds TNFRI with high affinity (K(d) of 0.6 nm), whereas TNFRII shows lower binding affinity (K(d) of 1.14 nm) to TNF-alpha in NT2 transfected cells. Together, these studies reveal novel neuronal responses of TNF-alpha in mediating consequences of TNF receptor activation differently. Subsequent neuronal death or survival may ultimately depend on a particular subtype of TNF receptor that is predominately expressed in neurons of the brain during neural development or with neurological diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Glutamate neurotoxicity and diseases of the nervous system
CHOI, D. (1988) · Neuron · doi:10.1016/0896-6273(88)90162-6 · Cited by 7,972
The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation
Hsu, H., Xiong, J., & Goeddel, D. V. (1995) · Cell · doi:10.1016/0092-8674(95)90070-5 · Cited by 2,012
Liu, Z.-G., Hsu, H., Goeddel, D. V., & Karin, M. (1996) · Cell · doi:10.1016/s0092-8674(00)81375-6 · Cited by 1,937
Signal transduction by tumor necrosis factor and its relatives
Baud, V., & Karin, M. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(01)02064-5 · Cited by 1,655
A novel domain within the 55 kd TNF receptor signals cell death
Tartaglia, L. A., Ayres, T. M., Wong, G. H. W., & Goeddel, D. V. (1993) · Cell · doi:10.1016/0092-8674(93)90464-2 · Cited by 1,288
TNFα promotes proliferation of oligodendrocyte progenitors and remyelination
Arnett, H. A., Mason, J., Marino, M., Suzuki, K., Matsushima, G. K., & Ting, J. P.-Y. (2001) · Nature Neuroscience · doi:10.1038/nn738 · Cited by 1,012 · cited 1×
“…al., 1992; D’Souza et al., 1995; Rothwell and Luheshi, 1996; Akassoglou et al., 1997; Hisahara et al., 1997; Nawashiro et al., 1997; Shen et al., 1997; Kim et al., 2001), but it is trophic (Cheng et al., 1994; Barger et al., 1995; Liu et al., 1998; Arnett et al., 2001) to rat hippocampal neurons.”
BackgroundMolecular cloning and expression of a receptor for human tumor necrosis factor
Schall, T. J., Lewis, M., Koller, K. J., Lee, A., Rice, G. C., Wong, G. H. W., Gatanaga, T., Granger, G. A., Lentz, R., Raab, H., et al. (1990) · Cell · doi:10.1016/0092-8674(90)90816-w · Cited by 964
Bruce, A. J., Boling, W., Kindy, M. S., Peschon, J., Kraemer, P. J., Carpenter, M. K., Holtsberg, F. W., & Mattson, M. P. (1996) · Nature Medicine · doi:10.1038/nm0796-788 · Cited by 932
Inflammatory Mediators and Stroke: New Opportunities for Novel Therapeutics
Barone, F. C., & Feuerstein, G. Z. (1999) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199908000-00001 · Cited by 930
Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor
Loetscher, H., Pan, Y.-C. E., Lahm, H.-W., Gentz, R., Brockhaus, M., Tabuchi, H., & Lesslauer, W. (1990) · Cell · doi:10.1016/0092-8674(90)90815-v · Cited by 905
Tumor necrosis factor identified in multiple sclerosis brain.
Hofman, F. M., Hinton, D. R., Johnson, K., & Merrill, J. E. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.2.607 · Cited by 801
Chemokines in pathology and medicine
Baggiolini, M. (2001) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2001.00867.x · Cited by 677
Cheng, B., Christakos, S., & Mattson, M. P. (1994) · Neuron · doi:10.1016/0896-6273(94)90159-7 · Cited by 668
Barger, S. W., Hörster, D., Furukawa, K., Goodman, Y., Krieglstein, J., & Mattson, M. P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9328 · Cited by 631
Pleasure, S., Page, C., & Lee, V. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-05-01802.1992 · Cited by 608
Tumour necrosis factor-α in murine autoimmune 'lupus' nephritis
Jacob, C. O., & McDevitt, H. O. (1988) · Nature · doi:10.1038/331356a0 · Cited by 596
Erickson, S. L., de Sauvage, F. J., Kikly, K., Carver-Moore, K., Pitts-Meek, S., Gillett, N., Sheehan, K. C. F., Schreiber, R. D., Goeddel, D. V., & Moore, M. W. (1994) · Nature · doi:10.1038/372560a0 · Cited by 588
TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination
Liu, J., Marino, M. W., Wong, G., Grail, D., Dunn, A., Bettadapura, J., Slavin, A. J., Old, L., & Bernard, C. C. A. (1998) · Nature Medicine · doi:10.1038/nm0198-078 · Cited by 550
Elevated circulating tumor necrosis factor levels in Alzheimer's disease
Fillit, H., Ding, W., Buee, L., Kalman, J., Altstiel, L., Lawlor, B., & Wolf-Klein, G. (1991) · Neuroscience Letters · doi:10.1016/0304-3940(91)90490-k · Cited by 512
Chao, M. V. (1994) · Journal of Neurobiology · doi:10.1002/neu.480251106 · Cited by 479
Malgaroli, A., & Tsien, R. W. (1992) · Nature · doi:10.1038/357134a0 · Cited by 417
Pro- versus anti-inflammatory cytokines: myth or reality.
Cavaillon, J. (2001) · PubMed · Cited by 410
Inflammatory repertoire of Alzheimer's disease and nondemented elderly microglia in vitro
Lue, L., Rydel, R., Brigham, E. F., Yang, L., Hampel, H., Murphy, G. M., Brachova, L., Yan, S., Walker, D. G., Shen, Y., et al. (2001) · Glia · doi:10.1002/glia.1072 · Cited by 382
Self-citationJacob, C. O., Aiso, S., Michie, S. A., McDevitt, H. O., & Acha-Orbea, H. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.3.968 · Cited by 349
TNF-α Pretreatment Induces Protective Effects against Focal Cerebral Ischemia in Mice
Nawashiro, H., Tasaki, K., Ruetzler, C. A., & Hallenbeck, J. M. (1997) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199705000-00001 · Cited by 340
Leist, M., Gantner, F., Jilg, S., & Wendel, A. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.3.1307 · Cited by 332
Akassoglou, K., Bauer, J., Kassiotis, G., Pasparakis, M., Lassmann, H., Kollias, G., & Probert, L. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65622-2 · Cited by 316
Cytokines in Parkinson’s disease
Nagatsu, T., Mogi, M., Ichinose, H., & Togari, A. (2000) · Advances in Research on Neurodegeneration · doi:10.1007/978-3-7091-6284-2_12 · Cited by 308
Inflammatory mechanisms in Alzheimer's disease
Eikelenboom, P., Zhan, S.-S., van Gool, W. A., & Allsop, D. (1994) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(94)90057-4 · Cited by 291
Akama, K. T., & Van Eldik, L. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.11.7918 · Cited by 287
Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain.
Dowling, P., Shang, G., Raval, S., Menonna, J., Cook, S., & Husar, W. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.4.1513 · Cited by 273
The p70 tumor necrosis factor receptor mediates cytotoxicity
Holler, R. A., Song, K., Fan, N., & Chang, D. J. (1992) · Cell · doi:10.1016/0092-8674(92)90532-h · Cited by 266
Epidemiology and predictors of fractures associated with osteoporosis
Lips, P. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)90021-8 · Cited by 259
Akassoglou, K., Probert, L., Kontogeorgos, G., & Kollias, G. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.1.438 · Cited by 256
Gary, D. S., Bruce-Keller, A. J., Kindy, M. S., & Mattson, M. P. (1998) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199812000-00001 · Cited by 249
Cell death induction by receptors of the TNF family: towards a molecular understanding
Wallach, D., Boldin, M., Varfolomeev, E., Beyaert, R., Vandenabeele, P., & Fiers, W. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00553-x · Cited by 233
The central nervous system as an immunocompetent organ: role of glial cells in antigen presentation
Shrikant, P., & Benveniste, E. N. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.5.1819 · Cited by 232
Yu, Z., Zhou, D., Bruce-Keller, A. J., Kindy, M. S., & Mattson, M. P. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-20-08856.1999 · Cited by 213
Yates, S. L., Burgess, L. H., Kocsis‐Angle, J., Antal, J. M., Dority, M. D., Embury, P. B., Piotrkowski, A. M., & Brunden, K. R. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0741017.x · Cited by 202
Interleukin 3 as a trophic factor for central cholinergic neurons in vitro and in vivo
Kamegai, M., Niijima, K., Kunishita, T., Nishizawa, M., Ogawa, M., Araki, M., Ueki, A., Konishi, Y., & Tabira, T. (1990) · Neuron · doi:10.1016/0896-6273(90)90055-k · Cited by 184
Self-citationD'Souza, S., Alinauskas, K., McCrea, E., Goodyer, C., & Antel, J. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-11-07293.1995 · Cited by 180
Kim, G.-M., Xu, J., Xu, J., Song, S., Yan, P., Ku, G., Xu, X., & Hsu, C. Y. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-17-06617.2001 · Cited by 177
Current Concepts in the Pathogenesis of Alzheimer’s Disease
Carr, D. B., Goate, A., Phil, D., & Morris, J. C. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)00262-3 · Cited by 158
ICE/CED‐3 Family Executes Oligodendrocyte Apoptosis by Tumor Necrosis Factor
Hisahara, S., Shoji, S., Okano, H., & Miura, M. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69010010.x · Cited by 141
Glia Increase Degeneration of Hippocampal Neurons through Release of Tumor Necrosis Factor-α
Viviani, B., Corsini, E., Galli, C. L., & Marinovich, M. (1998) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1998.8406 · Cited by 128
Collins, J. S., Perry, R. T., Watson, B., Harrell, L. E., Acton, R. T., Blacker, D., Albert, M., Tanzi, R. E., Bassett, S. S., McInnis, M. G., et al. (2000) · American Journal of Medical Genetics · doi:10.1002/1096-8628(20001204)96:6<823::aid-ajmg26>3.0.co;2-i · Cited by 128
Shen, Y., Li, R., & Shiosaki, K. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.6.3550 · Cited by 109
Self-citationDSouza, S., Alinauskas, K. A., & Antel, J. P. (1996) · Journal of Neuroscience Research · Cited by 96
Genetic analysis of immunomodulating factors in sporadic Parkinson's disease
Krüger, R., Hardt, C., Tschentscher, F., Jäckel, S., Kuhn, W., Müller, T., Werner, J., Woitalla, D., Berg, D., Kühnl, N., et al. (2000) · Journal of Neural Transmission · doi:10.1007/s007020070078 · Cited by 94
An endogenous 55 kDa TNF receptor mediates cell death in a neural cell line
Sipe, K. J., Srisawasdi, D., Dantzer, R., Kelley, K. W., & Weyhenmeyer, J. A. (1996) · Molecular Brain Research · doi:10.1016/0169-328x(95)00310-o · Cited by 58
Cytokines in Parkinson’s Disease
Nagatsu, T., & Mogi, M. (1998) · Advances in behavioral biology · doi:10.1007/978-1-4615-5337-3_58 · Cited by 54
Brain TNF: Damage limitation or damaged reputation?
Rothwell, N. J., & Luheshi, G. N. (1996) · Nature Medicine · doi:10.1038/nm0796-746 · Cited by 40
p38β MAP kinase protects rat mesangial cells from TNF‐α‐induced apoptosis
Guo, Y., Kang, B., Han, J., & WILLIAMSON, J. R. (2001) · Journal of Cellular Biochemistry · doi:10.1002/jcb.1180 · Cited by 39
Cited by
Glutamate neurotoxicity and diseases of the nervous system
CHOI, D. (1988) · Neuron · doi:10.1016/0896-6273(88)90162-6 · Cited by 7,972
Differential Regulation of AMPA Receptor and GABA Receptor Trafficking by Tumor Necrosis Factor-α
Stellwagen, D., Beattie, E. C., Seo, J. Y., & Malenka, R. C. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4486-04.2005 · Cited by 985
“Cytokines and cytokine receptor materials were from R & D Systems (Minneapolis, MN), except the TNFR2 activating antibodies, which were from Abcam (Cambridge, MA).”
BackgroundInfluentialTNF-α and neuropathic pain - a review
Leung, L., & Cahill, C. M. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-27 · Cited by 630
Cerebral ischemia and inflammation
Iadecola, C., & Alexander, M. (2001) · Current Opinion in Neurology · doi:10.1097/00019052-200102000-00014 · Cited by 466
Iosif, R. E., Ekdahl, C. T., Ahlenius, H., Pronk, C. J. H., Bonde, S., Kokaia, Z., Jacobsen, S.-E. W., & Lindvall, O. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.2723-06.2006 · Cited by 463
Metadata
- Authors
- Yang, L., Lindholm, K., Konishi, Y., Li, R., & Shen, Y.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2002-04-15
- Volume
- 22
- Issue
- 8
- Pages
- 3025-3032
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W1724950598
- Cited by
- 256
- References
- 53
- FWCI
- 6.93
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.